Washington [US], May 27 (ANI): Sodium-glucose transporter-2 (SGLT2) inhibitors, which reduce renal glucose reabsorption, may help control blood sugar and protect kidney health in patients with diabetic renal failure; however, several large clinical trials have linked these drugs to a higher risk of bone fracture.
Washington [US], January 16 (ANI): Less than one in five adults with Type 2 diabetes in the US meet health targets to reduce heart disease risk, a new study has found.
\
\
\
\
